Lensar today announced the first commercial cases were performed with its Ally adaptive cataract treatment system.
The first procedures were performed by Dr. Robert Weinstock at The Eye Institute of West Florida, where he performed 15 laser-assisted cataract surgery cases following the recent installation of the Ally system.
Ally was FDA cleared in June 2022 and was designed by Lensar to facilitate completing the entire cataract surgery procedure in a single, sterile setting to reduce the overall time and improving the experience for the patient and surgeon.
“This marks the culmination of our dedication and focus to bringing the next generation technology to cataract surgeons. We are proud to partner with Dr. Weinstock as the first surgeon to integrate Ally into his renowned practice for refractive cataract surgery. Dr. Weinstock brings a wealth of surgical expertise and is leading this paradigm shift for cataract surgeons,” CEO Nick Curtis said in a news release. “I’d also like to personally thank Dr. Weinstock for his unwavering belief in Lensar and for working closely with us through the years.”
Lensar has been working with cataract surgeons and surgery centers to integrate the Ally system. The system’s features are designed to enable surgeons to deliver improved clinical outcomes. It has augmented reality and cataract density imaging to give surgeons a new level of guidance and confidence while performing surgery, according to the company.
The company said it plans to install eight to 12 Ally systems this year as part of a controlled, commercial launch.
“Ally is changing the way surgeons are approaching cataract surgery. With improved efficiencies, Ally is designed to enable surgeons to offer a premium cataract surgery experience to more patients. Ally is primed to assist surgeons in meeting the increasing demands of the large, fast-growing, cataract patient population with a premium, efficient experience,” Curtis said. “We look forward to strengthening our relationships and providing responsive, best-in-class customer service to each center using Lensar technologies. With Ally coming to market at a time where first-generation femtosecond lasers have significantly aged, ALLY provides an opportunity for surgeons to continue to provide laser cataract surgery with a reliable, next-generation platform. Lensar’s first-generation LLS systems have demonstrated a 99.7% uptime rating – a true laser workhorse – and we are aiming for Ally to exceed these service ratings. Overall, our objective is to exceed surgeon, staff and patient expectations across all measures of performance.”